-
Speaking Naturally with Sylvie Beljanski and Nathan Crane
06 September 2023
Following the news that ANH-USA is to be given a prestigious award by the Beljanski Foundation, Rob Verkerk PhD openly engages with Sylvie Beljanski and Nathan Crane about the Foundation's background and current work, including the upcoming 'Winning the War on Cancer' conference in Florida
-
ANH News Beat (week 39/2023)
27 September 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
FEATURE: The cancer breakthroughs most never get to hear about
26 October 2023
An all-star cast of integrative cancer clinicians came together for the Beljanski Integrative Cancer Conference in Jacksonville, Florida, to share their life saving knowledge and findings, while ANH-USA receives award
-
Pathfinder Members' Briefing and Q&A - July 2023
13 July 2023
Zoom recording of July's Pathfinder members' briefing and Q&A
-
Pathfinder Members' Briefing and Q&A - July 2023
13 July 2023
Zoom recording of July's Pathfinder members' briefing and Q&A
-
ANH News Beat (week 38/2023)
20 September 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
Peptide bioregulators presentation
18 July 2023
This presentation on peptide bioregulators is available to all Pathfinder members with an interest in their mechanisms and how they might help support our overall health
-
How do the current EU rules & regulations affect your practice?
18 July 2023
All practitioners, whether medically qualified or qualified in some other way, are affected one way or another by EU laws if they live, or more importantly practice, anywhere within the European Union (EU).
-
August Acceleration 2023: Reclaiming Our Potential
03 August 2023
Meleni Aldridge introduces this year’s self-development track and gives context to the nature of the theme
-
Pathfinder Members' Briefing and Q&A - May 2023
17 May 2023
Zoom recording of May's Members' Briefing and Q&A